Thank you, Mr. Chair.
I want to thank the witnesses for participating in this committee meeting.
Apparently mefloquine, marketed by the F. Hoffmann-La Roche AG pharmaceutical company under the name Lariam, stopped being available in Canada in 2013. However, the generic drug is still available.
First, can you explain why the brand name drug was withdrawn and not the generic drug?
Second, were comparative studies of mefloquine carried out with civilians?
I'll leave the question open. I think Mr. Nevin has some answers.